journal article·2014-01

A helix-PXXP-helix peptide with antibacterial activity without cytotoxicity against MDRPA-infected mice

Jong-Kook Lee, Seong-Cheol Park, Kyung-Soo Hahm, Yoonkyung Park

Biomaterials· Volume 35· Issue 3
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Antimicrobial Peptides and Activities · Immune Response and Inflammation · Antibiotic Resistance in Bacteria

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (48)

Show source-provided references
1. Antimicrobial peptides: primeval molecules or future drugs?10.1371/journal.ppat.1001067 ↗
2. Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia10.1186/1471-2180-12-145 ↗
3. Antibiotic resistance of mixed biofilms in cystic fibrosis: impact of emerging microorganisms on treatment of infection10.1016/j.ijantimicag.2012.04.020 ↗
4. Lack of the long pentraxin PTX3 promotes autoimmune lung disease but not glomerulonephritis in murine systemic lupus erythematosus10.1371/journal.pone.0020118 ↗
5. Endogenous MCP-1 promotes lung inflammation induced by LPS and LTA10.1016/j.molimm.2011.04.001 ↗
6. Temporins and their synergism against Gram-negative bacteria and in lipopolysaccharide detoxification10.1016/j.bbamem.2009.04.021 ↗
7. Antimicrobial peptides: successes, challenges and unanswered questions10.1007/s00232-011-9343-0 ↗
8. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?10.1038/nrmicro1098 ↗
9. Mechanisms of antimicrobial peptide action and resistance10.1124/pr.55.1.2 ↗
10. The role of antimicrobial peptides in animal defenses10.1073/pnas.97.16.8856 ↗
11. Interaction of cationic peptides with lipoteichoic acid and gram-positive bacteria10.1128/IAI.67.12.6445-6453.1999 ↗
12. Lipid-mediated resistance of Gram-negative bacteria against various pore-forming antimicrobial peptides10.1177/09680519050110030501 ↗
13. Tumor necrosis factor-alpha induces functionally active hyaluronan-adhesive CD44 by activating sialidase through p38 mitogen-activated protein kinase in lipopolysaccharide-stimulated human monocytic cells10.1074/jbc.M302309200 ↗
14. Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: benefits and hazards of LPS hypersensitivity10.1016/j.imbio.2007.11.008 ↗
15. Bacterial cell surface polysaccharides10.1146/annurev.bi.42.070173.000515 ↗
16. Bifunctional penicillin-binding proteins: focus on the glycosyltransferase domain and its specific inhibitor moenomycin10.2174/1389201023378436 ↗
17. Beta-lactam antibiotic resistance: a current structural perspective10.1016/j.mib.2005.08.016 ↗
18. The role played by lipids unsaturation upon the membrane interaction of the Helicobacter pylori HP(2-20) antimicrobial peptide analogue HPA310.1007/s10863-009-9204-z ↗
19. Antibacterial peptide from H. pylori10.1038/19439 ↗
20. Design of novel analogue peptides with potent antibiotic activity without hemolytic activity based on the antimicrobial peptide derived from N-terminal sequence of Helicobacter pylori ribosomal protein L110.1016/S0167-4838(02)00373-4 ↗
21. A proline-hinge alters the characteristics of the amphipathic α-helical AMPs10.1371/journal.pone.0067597 ↗
22. Proline-rich antimicrobial peptides: converging to a non-lytic mechanism of action10.1007/s00018-011-0721-7 ↗
23. Aggregation and organization of pardaxin in phospholipid membranes. A fluorescence energy transfer study10.1016/S0021-9258(19)50456-2 ↗
24. Comparative study of the membrane-permeabilizing activities of mastoparans and related histamine-releasing agents in bacteria, erythrocytes, and mast cells10.1016/j.bbamem.2010.10.007 ↗
25. Characterization of a heat-stable protein with antimicrobial activity from Arabidopsis thaliana10.1016/j.bbrc.2007.07.188 ↗
26. LPS challenge in d-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock10.1164/ajrccm.159.4.9712012 ↗
27. Design, synthesis, and evaluation of a new fluorescent probe for measuring polymyxin-lipopolysaccharide binding interactions
28. Mode of action of human beta-defensin 3 against Staphylococcus aureus and transcriptional analysis of responses to defensin challenge10.1016/j.ijmm.2008.01.011 ↗
29. Investigation of toroidal pore and oligomerization by melittin using transmission electron microscopy10.1016/j.bbrc.2006.02.090 ↗
30. Anti-inflammatory effects of 8-hydroxy-2'-deoxyguanosine on lipopolysaccharide-induced inflammation via Rac suppression in Balb/c mice10.1016/j.freeradbiomed.2007.08.022 ↗
31. Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: evidence for multiple conformations involved in binding to membranes and DNA10.1093/nar/gki725 ↗
32. Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action10.1074/jbc.M504327200 ↗
33. Low dose of carbon monoxide intraperitoneal injection provides potent protection against GalN/LPS-induced acute liver injury in mice
34. Antibiotic and synergistic effect of Leu-Lys rich peptide against antibiotic resistant microorganisms isolated from patients with cholelithiasis10.1016/j.bbrc.2010.07.118 ↗
35. Antifungal mechanism of a novel antifungal protein from pumpkin rinds against various fungal pathogens10.1021/jf902005g ↗
36. Buforins: histone H2A-derived antimicrobial peptides from toad stomach10.1016/j.bbamem.2008.10.025 ↗
37. Cell-selective lysis by novel analogues of melittin against human red blood cells and Escherichia coli10.1021/bi100729m ↗
38. Neutrophil defensins: purification, characterization and antimicrobial testing
39. Efficiency of erythromycin lactobionate for treating Pseudomonas aeruginosa bacteremia in mice10.1128/AAC.36.6.1198 ↗
40. Cathelicidin-related antimicrobial peptide is required for effective lung mucosal immunity in Gram-negative bacterial pneumonia10.4049/jimmunol.1103196 ↗
41. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction10.1016/0003-2697(79)90738-3 ↗
42. Tissue sulfhydryl group10.1016/0003-9861(59)90090-6 ↗
43. Lipid peroxidation and lysosomal enzymes in d-galactosamine hepatitis and its protection by vitamin E10.1007/BF02774602 ↗
44. Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions10.1016/j.bbamem.2007.09.020 ↗
45. Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity10.1111/j.1574-6968.2004.tb09482.x ↗
46. Parameters involved in antimicrobial and endotoxin detoxification activities of antimicrobial peptides10.1021/bi800450f ↗
47. The epidemiology of sepsis in the United States from 1979 through 200010.1056/NEJMoa022139 ↗
48. Absence of in vitro innate immunomodulation by insect-derived short proline-rich antimicrobial peptides points to direct antibacterial action in vivo10.1002/psc.2440 ↗